Pharvaris N.V.
Organization details
- Legal name
- Pharvaris N.V.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Netherlands
- Headquarters city
- Leiden
- Headquarters country
- Netherlands
- Fiscal year end
- December
- Ticker symbol
- PHVS
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001830487
Board of directors
-
Berndt Modig · Director · Chief Executive OfficerSince 2026
-
David P. Meeker · DirectorSince 2026
-
Elisabeth Bjork · DirectorSince 2026
-
Johannes Gerardus Christiaan Petrus Schikan · DirectorSince 2026
-
Robert Glassman · DirectorSince 2026
-
Viviane Monges · DirectorSince 2026
Chief executives
Board connections
3 of this board's directors also sit on 5 other boards. 5 are in the same sector.
-
ADC Therapeutics SA Same sectorvia Viviane Monges
-
Kardigan Inc. Same sectorvia David P. Meeker
-
Rhythm Pharmaceuticals Inc. Same sectorvia David P. Meeker
-
Rocket Pharmaceuticals Inc. Same sectorvia Elisabeth Bjork
-
Trevi Therapeutics Inc. Same sectorvia David P. Meeker
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $33,020,918
- 71 sales by 11 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 12, 2026 | Lu Peng Officer (President) | Shares withheld for tax | −117 | $31.10 | $3,639 |
| Oct 11, 2026 | Lu Peng Officer (President) | Shares withheld for tax | −109 | $31.10 | $3,390 |
| Sep 23, 2026 | Viviane Monges Director | Option exercise | +11,969 | $8.05 | $96,350 |
| Sep 23, 2026 | Viviane Monges Director | Open-market sale | −11,969 | $33.05 | $395,575 |
| Sep 22, 2026 | Lu Peng Officer (President) | Option exercise | +45,308 | $2.59 | $117,348 |
| Sep 22, 2026 | Johannes Gerardus Christiaan Petrus Schikan Director | Option exercise | +800 | $20.00 | $16,000 |
| Sep 22, 2026 | Johannes Gerardus Christiaan Petrus Schikan Director | Open-market sale | −800 | $36.19 | $28,952 |
| Sep 21, 2026 | Nassif David W. Officer (CFO / CLO) | Open-market sale | −6,000 | $36.47 | $218,820 |
| Sep 21, 2026 | Nassif David W. Officer (CFO / CLO) | Gift | −500 | — | — |
| Sep 17, 2026 | Elisabeth Bjork Director | Option exercise | +35,000 | $14.39 | $503,650 |
| Sep 17, 2026 | Robert Glassman Director | Option exercise | +14,493 | $18.14 | $262,903 |
| Sep 17, 2026 | Lesage Anne Officer (Chief Early Development) | Open-market sale | −20,000 | $38.27 | $765,400 |
| Sep 17, 2026 | Lu Peng Officer (President) | Option exercise | +100,000 | $2.59 | $259,000 |
| Sep 17, 2026 | Berndt Modig Director, Officer (Chief Executive Officer) | Option exercise | −300,000 | $35.00 | $10,500,000 |
| Sep 17, 2026 | Johannes Gerardus Christiaan Petrus Schikan Director | Open-market sale | −200,000 | $35.00 | $7,000,000 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Pharvaris N.V.
Who is the CEO of Pharvaris N.V.?
Berndt Modig has been Pharvaris N.V.'s Chief Executive Officer since March 2026.
How many directors are on Pharvaris N.V.'s board?
Pharvaris N.V.'s board has 6 directors: Berndt Modig, David P. Meeker, Elisabeth Bjork, Johannes Gerardus Christiaan Petrus Schikan, Robert Glassman and Viviane Monges.
Are Pharvaris N.V. insiders buying or selling shares?
Over the last 12 months, Pharvaris N.V. insiders made no open-market purchases and sold $33.0 million of shares in 71 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="pharvaris-nv"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.